Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1956 2
1957 3
1958 1
1959 1
1962 3
1963 2
1965 1
1966 3
1967 1
1968 4
1970 1
1971 1
1972 1
1974 2
1975 3
1976 2
1977 1
1978 4
1979 3
1980 3
1981 7
1982 4
1983 7
1984 13
1985 12
1986 14
1987 15
1988 20
1989 24
1990 30
1991 51
1992 38
1993 30
1994 47
1995 52
1996 39
1997 59
1998 62
1999 72
2000 55
2001 55
2002 95
2003 81
2004 92
2005 86
2006 103
2007 95
2008 60
2009 62
2010 63
2011 68
2012 68
2013 90
2014 64
2015 41
2016 51
2017 52
2018 59
2019 71
2020 74
2021 63
2022 89
2023 87
2024 63

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,251 results

Results by year

Filters applied: . Clear all
Page 1
Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer.
Jiang Y, Wang Y, Chen G, Sun F, Wu Q, Huang Q, Zeng D, Qiu W, Wang J, Yao Z, Liang B, Li S, Wu J, Huang N, Wang Y, Chen J, Zhai X, Huang L, Xu B, Yamamoto M, Tsukamoto T, Nomura S, Liao W, Shi M. Jiang Y, et al. Among authors: tsukamoto t. Cell Metab. 2024 Aug 6;36(8):1806-1822.e11. doi: 10.1016/j.cmet.2024.05.013. Epub 2024 Jun 18. Cell Metab. 2024. PMID: 38897198 Free article.
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells.
Kumagai S, Togashi Y, Sakai C, Kawazoe A, Kawazu M, Ueno T, Sato E, Kuwata T, Kinoshita T, Yamamoto M, Nomura S, Tsukamoto T, Mano H, Shitara K, Nishikawa H. Kumagai S, et al. Among authors: tsukamoto t. Immunity. 2020 Jul 14;53(1):187-203.e8. doi: 10.1016/j.immuni.2020.06.016. Epub 2020 Jul 7. Immunity. 2020. PMID: 32640259 Free article.
Targeting sensory neuron GPCRs for peripheral neuropathic pain.
Uniyal A, Tiwari V, Tsukamoto T, Dong X, Guan Y, Raja SN. Uniyal A, et al. Among authors: tsukamoto t. Trends Pharmacol Sci. 2023 Dec;44(12):1009-1027. doi: 10.1016/j.tips.2023.10.003. Epub 2023 Nov 11. Trends Pharmacol Sci. 2023. PMID: 37977131 Review.
Clinical development of metabolic inhibitors for oncology.
Lemberg KM, Gori SS, Tsukamoto T, Rais R, Slusher BS. Lemberg KM, et al. Among authors: tsukamoto t. J Clin Invest. 2022 Jan 4;132(1):e148550. doi: 10.1172/JCI148550. J Clin Invest. 2022. PMID: 34981784 Free PMC article. Review.
Giant Rectus Sheath Hematoma: Pseudobladder Sign.
Shiba H, Endo T, Fujikawa H, Tsukamoto T. Shiba H, et al. Among authors: tsukamoto t. JMA J. 2023 Jul 14;6(3):348-349. doi: 10.31662/jmaj.2023-0028. Epub 2023 May 22. JMA J. 2023. PMID: 37560371 Free PMC article. No abstract available.
Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomas.
Katsuragawa-Taminishi Y, Mizutani S, Kawaji-Kanayama Y, Onishi A, Okamoto H, Isa R, Mizuhara K, Muramatsu A, Fujino T, Tsukamoto T, Shimura Y, Taniwaki M, Miyagawa-Hayashino A, Konishi E, Kuroda J. Katsuragawa-Taminishi Y, et al. Among authors: tsukamoto t. Cancer Sci. 2023 Dec;114(12):4691-4705. doi: 10.1111/cas.15995. Epub 2023 Oct 15. Cancer Sci. 2023. PMID: 37840379 Free PMC article.
2,251 results